Included in the formulation
АТХ:G.04.B.X Other drugs for the treatment of urological diseases
Pharmacodynamics:Combined drug. Has analgesic, bacteriostatic and anti-inflammatory effect. Affects the pathogenesis of benign prostatic hyperplasia. Reduces pain in the prostate and improves urination. Contains a large number of unsaturated fatty acids, antioxidants and trace elements. Has antibacterial properties, highly effective against cocci. The rectal route of administration of the drug in chronic prostatitis allows a rapid onset of the therapeutic effect and excludes the possible inactivation of the drug in the gastrointestinal tract. The therapeutic concentration is achieved in secretion and prostate tissue, which allows to reduce the inflammatory reaction in the prostate gland.
Pharmacokinetics:Not studied
Indications:Chronic bacterial and abacterial prostatitis.
Benign prostatic hyperplasia (symptomatic therapy).
XIV.N40-N51.N40 Hyperplasia of the prostate
XIV.N40-N51.N41 Inflammatory diseases of the prostate
Contraindications:Hypersensitivity to the drug.
Carefully:Hypersensitivity.
Pregnancy and lactation:Not intended for use in women.
Category of recommendations for FDA is not defined.
Dosing and Administration:Rectal by 1 suppository 1-2 times a day for 14 days. Repeated courses of treatment - after consultation with a doctor.
Side effects:From the side digestive system: rarely - indigestion, diarrhea.
In rare cases, possible allergic reactions.
Interaction:Not studied
The drug is compatible with any food.
Special instructions:In inflammatory and degenerative processes of the upper gastrointestinal mucosa recommended to take the drug in the form of oil, should avoid taking the drug in the form of capsules.